Meet the 5.7%-Yielding Value Stock That's on Track to Become a Dividend King Next Year

Clorox (NYSE: CLX) boosted its dividend for the 48th consecutive year last July. Clorox has yet to announce another raise, but it remains on track to achieve the sought-after 50-year dividend streak in 2027, which would make it a Dividend King.

Clorox's rising dividend, paired with its falling stock price, has pushed its yield to a multi-decade high of 5.7%.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Here's why Clorox remains committed to its dividend despite challenges in its underlying business, and why the value stock is a great buy now.

An ongoing theme in the household and personal products industry is that private-label brands like Costco Wholesale's Kirkland Signature, Walmart's Great Value, and Sam's Club's Member's Mark are gobbling up market share from name brands.

Clorox CEO Linda Rendle said the following on Clorox's third-quarter fiscal 2026 earnings call on May 1: "But overall, private label just hasn't had the impact that many would have expected. And I know many of you are asking questions about that. We've continued to see it play the role that it normally does, which is offering a low price for those consumers who need it."

Clorox said that private-label market share remained flat in its quarter, as consumers continue to shop for high-quality brands. "But generally, consumers continue to want brands, and they continue to want value overall, not just the lowest price," said Rendle.

Private label is far from Clorox's only concern. The company is facing pressure from competitors' promotions and discounts, especially in the food category. Clorox is using product innovation, preferred shelf placement, and marketing efforts to help offset these pressures. But the business is clearly being affected, as Clorox now forecasts a 9% decline in full-year fiscal 2026 organic sales compared to guidance from just three months ago of a 5% to 9% decline. This means that Clorox's pessimistic outlook is coming to fruition.

In addition to asset sales, cost cuts, pricing pressure, and intense competition, Clorox has been undergoing a major Enterprise Resource Planning (ERP) overhaul.

In February, Clorox announced the completion of its five-year, $580 million ERP implementation, upgrading a more than 20-year-old system to a new SAP cloud-based system that integrates financial, supply chain, and sales. The new system should make the overall business more efficient. But the transition has been extremely messy, namely due to its effect on Clorox's supply chain.

Clorox's brutal sell-off is a reminder of how much investors hate uncertainty. Management underestimated the duration and cost of the ERP transition, as well as the severity of the slowdown in consumer spending. The company has also been making major changes to its portfolio. These include the sale of its Vitamins, Minerals, and Supplements business and divestments from Argentina, Uruguay, and Paraguay in calendar year 2024, and the $2.25 billion acquisition of Purell owner GOJO Industries in April of this year.

On top of these changes, Clorox has been unable to provide reliable guidance, often totally missing its numbers or consistently guiding down.

All told, the sell-off in Clorox is totally understandable. But long-term investors care more about where a stock is going than where it has been. Clorox has the makings of a potential turnaround opportunity for patient investors, especially given its dirt cheap valuation and high yield.

Before you buy stock in Clorox, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Clorox wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $476,034!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,274,109!*

Now, it’s worth noting Stock Advisor’s total average return is 975% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

*Stock Advisor returns as of May 7, 2026.

Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Costco Wholesale and Walmart. The Motley Fool recommends SAP. The Motley Fool has a disclosure policy.

Meet the 5.7%-Yielding Value Stock That's on Track to Become a Dividend King Next Year was originally published by The Motley Fool